Tanabe Masaki, Kodama Kenji, Asada Kohei, Kunitomo Takeo
Department of Cardiology, Kyoto Okamoto Memorial Hospital, 58 Sayama Nishinokuchi, Kumiyama, Kyoto, 611-0034, Japan.
Department of Cardiology, Nagahama Red Cross Hospital, Nagahama, Shiga, Japan.
Heart Vessels. 2018 Jun;33(6):573-582. doi: 10.1007/s00380-017-1091-3. Epub 2017 Dec 9.
This study was performed to investigate lesion characteristics and procedural outcomes of re-attempted percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). Prior failure of percutaneous revascularization of CTO has been identified as an independent predictor of failure at subsequent attempts. However, procedural outcomes of re-attempted PCI for CTO have not been elucidated. We evaluated lesion characteristics and procedural outcomes in 310 consecutive patients undergoing CTO-PCI, and compared the results between re-attempted (n = 59) and initial procedures (n = 251). Overall, 266 CTO lesions (85.8%) were treated successfully. In addition, the technical success rate in the re-attempted CTO lesions was 69.5% (41 of 59), although this was lower than for initially attempted lesions (89.6%, 225 of 251; P = 0.0021). In the details of reasons of previous failures, treatment devices failed to cross even after guidewire cross and procedure discontinuation due to management of complications achieved higher rates of technical success compared to those with the inability of guidewire crossing in re-attempted CTO-PCI (87.5 and 85.7 vs. 65.9%, respectively). CTO lesions in which PCI was re-attempted had more complex features, including calcification, tortuous morphology, and long lesion length, whereas patient demographics were similar. Re-attempted CTO lesions required complex procedures, including the retrograde approach (55.9 vs. 13.9%, P < 0.001), longer fluoroscopic time, and larger radiation dose. Meanwhile, rates of complications and in-hospital MACCE were similarly low in both groups. The technical success rates of re-attempted CTO-PCI lesions were acceptable. Furthermore, CTO-PCIs in re-attempted lesions were as safe as initially attempted CTO-PCI. However, re-attempted CTO-PCI lesions showed features of high anatomical complexity that required more complex and longer procedures, including the retrograde approach, for successful interventional revascularization. Re-attempted CTO-PCI due to treatment devices failed to cross even after guidewire cross and procedure discontinuation due to management of complications in previous attempt had higher success rates that those with the inability of guidewire crossing.
本研究旨在调查再次尝试经皮冠状动脉介入治疗(PCI)慢性完全闭塞病变(CTO)的病变特征及手术结果。既往CTO经皮血管重建失败已被确定为后续尝试失败的独立预测因素。然而,再次尝试CTO-PCI的手术结果尚未阐明。我们评估了310例连续接受CTO-PCI患者的病变特征及手术结果,并比较了再次尝试组(n = 59)和初次手术组(n = 251)的结果。总体而言,266例CTO病变(85.8%)成功治疗。此外,再次尝试的CTO病变技术成功率为69.5%(59例中的41例),尽管低于初次尝试病变(89.6%,251例中的225例;P = 0.0021)。在既往失败原因的细节中,与再次尝试CTO-PCI时导丝无法通过的情况相比,治疗器械即使在导丝通过后仍无法通过以及因并发症处理而中止手术的情况,技术成功率更高(分别为87.5%和85.7%对65.9%)。再次尝试PCI的CTO病变具有更复杂的特征,包括钙化、迂曲形态和病变长度较长,而患者人口统计学特征相似。再次尝试的CTO病变需要复杂的手术,包括逆行途径(55.9%对13.9%,P < 0.001)、更长的透视时间和更大的辐射剂量。同时,两组并发症和院内主要不良心血管和脑血管事件(MACCE)发生率同样较低。再次尝试CTO-PCI病变的技术成功率是可以接受的。此外,再次尝试病变的CTO-PCI与初次尝试的CTO-PCI一样安全。然而,再次尝试的CTO-PCI病变显示出解剖复杂性高的特征,需要更复杂、更长的手术,包括逆行途径,以实现成功的介入血管重建。因治疗器械即使在导丝通过后仍无法通过以及因既往尝试中并发症处理而中止手术导致的再次尝试CTO-PCI,其成功率高于导丝无法通过的情况。